Cantor Fitzgerald Reiterates Overweight on HCA Healthcare, Maintains $335 Price Target
Portfolio Pulse from Benzinga Newsdesk
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on HCA Healthcare (NYSE:HCA) and maintained a price target of $335.
July 24, 2024 | 6:06 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Cantor Fitzgerald analyst Sarah James has reiterated an Overweight rating on HCA Healthcare and maintained a price target of $335.
The reiteration of an Overweight rating and a maintained price target of $335 by a reputable analyst can boost investor confidence in HCA Healthcare, likely leading to a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100